August 23-24, 2021
Online Livestream
Blockchain Pharma &Life Sciences Summit
Using Decentralized Technology to Improve Trust, Transparency and Security Throughout the Life Sciences Ecosystem

Blockchain technology creates unique opportunities to share complex and critical data with internal and external stakeholders. The pharmaceutical industry has a unique opportunity to leverage this technology to boost trust and improve transparency with key partners including regulators, contract manufacturers, physicians and patients. The COVID-19 pandemic highlighted the value of adopting blockchain technology to overcome challenges and address supply chain vulnerabilities. Additionally, blockchain-based technology has practical applications in other key areas including clinical research and drug development.

DGE’s inaugural Blockchain Pharma & Life Sciences Summit provides you with the most effective ways to utilize blockchain technology and the potential implications for the entire life sciences ecosystem.

Top Reasons to Attend
  • Real-time use of blockchain to strengthen the COVID vaccine supply chain
  • Innovative ways to ensure trust and transparency in clinical trials
  • All-new details on electronic product identification and preventing drug counterfeiting
  • Case studies presented by leaders in the life sciences industry
  • Unrivaled access and networking opportunities with leaders in blockchain on a proven interactive platform
Who Should Attend

This event is designed for life sciences professions with responsibilities in:

  • Supply Chain
  • Logistics
  • Clinical Planning
  • Clinical Operations
  • Data Management
  • Scientific Officers
  • Information Officers
  • Digital Innovation
  • Digital Solutions
  • Digital Transformation
  • Quality Assurance
  • Track and Trace
  • Data Technology
  • Data Management
  • Emerging Technology
  • Information Technology
  • Product Validation
  • Regulatory Affairs
  • Digital/Multi-Channel Marketing
  • Market Access

This virtual event will also be of interest to:

  • Blockchain Solutions Providers
  • Blockchain Consultation
  • Pharmacy Benefit Managers (PBMs)
  • CROs with Blockchain Practice
Event Sponsors
New Topics
Featured Speakers
Abdel Dridi
AI Chief Technologist
Alan Pelz-Sharpe
Founder & Principal Analyst
Deep Analysis
Daniel Fritz
PharmaLedger Industry Lead, Domain Architect Supply Chain and External Supply
Daniel Uribe
Co-Founder & CEO
Darshan Kulkarni
Pharm.D, MS, Esq.
Jay Bergeron
Director, Translational and Bioinformatics
Jose L. Arrieta
Former Chief Information Officer & Chief Data Officer
Maria Eugenia (Xenia) Beltran
PharmaLedger Project Manager
University of Madrid
Shameer Khader
Senior Director, AI/ML, Data Science, Digital Health and Bioinformatics
Shola Oyewole
Vice President – Digital Innovation
United Therapeutics
Swetha Naidu
Global Product Owner
Uma Sridharan
Senior Director, Business Intelligence & Analytics
Event Schedule
Blockchain technology is more than distributed ledger technology – it is a method to solving the social problem of trust. This session explores the full range of functions that blockchain can unlock within the life sciences ecosystem.
  • Define the key characteristics of blockchain
  • Identify major challenges within the industry and explore how blockchain technology can be part of the solution
  • Assess the risks and advantages to this highly disruptive technology
  • Develop a roadmap for your organization
The COVID-19 pandemic demonstrated the need for a digital solution to monitor compliance within the vaccine supply chain. Blockchain can provide environmental monitoring during transport and storage, provide visibility throughout the chain of custody, and ensure traceability in the event of a recall.
  • Hypothesize end-to-end use cases to eliminate supply chain vulnerabilities
  • Consider how smart contracts can be utilized to verify environmental conditions
  • Utilize blockchain to provide insights on inventory and ensure traceability
Clear use cases are emerging within the biopharmaceutical and medical device industries signaling the impact of blockchain solutions in providing transparency, traceability, and efficiency. As several pilots have been initiated, it is important to consider the challenges in advancing the use of this technology from proof of concept to full-scale implementation.
  • Review promising pilot/proof-of-concept work
  • Grasp challenges of expanding blockchain use from pilot to full-scale

In recent years, AI and digital technologies have been utilized to improve health outcomes. In market access, blockchain can provide key stakeholders with reliable real-time data and indisputable records, ultimately providing smarter, practical market access solutions. Ensuring all entities are part of the blockchain network poses a challenge.

  • Review the most challenging issues in market access and health economics
  • Conceptualize uses for blockchain to meet these challenges
  • Address barriers to successfully implementing a blockchain solution within this field
Employing a blockchain based system in clinical trials can provide an innovative solution to ensuring trust and transparency amongst all parties. In addition to improved data integrity, blockchain technology can allow for expanded patient recruitment and enable full trial decentralization.
  • Explore the use case for blockchain in improving the quality of clinical trial data and securing patient data
  • Focus on consent management in blockchain protocols
  • Recognize the limitations of using blockchain in clinical trials
For blockchain to be a successful solution, all entities must come together to establish data standards. Additionally, companies need to assess how their current data management systems can be integrated into new digital solutions.
  • Consider ways to establish data standards with multiple entities
  • Generate efficiencies by streamlining data exchanges between key stakeholders in the supply chain
  • Provide proper training and guidance for teams involved in implementing digital solutions
Blockchain technology benefits the highly regulated life sciences industry by allowing for transparent, efficient, and reliable data exchanges. However, as blockchain technology is still relatively new to the industry, we need to explore the legal and regulatory impact for drug and device manufacturers.
  • Review federal regulations pertaining to tracking and tracking products, clinical trials, and data privacy
  • Debate how these regulations may be affected when exploring blockchain solutions
  • Discuss accountability when data is shared across the globe
  • Discuss the impact from a federal and state level
Building personalized digital healthcare solutions to support clinical claims is of great importance to the drug industry. This session details the use of blockchain to solve and monitor medical device identity management for highly regulated SAMD/SIMD products.
  • Prioritize patient identity management and data privacy protection
  • Manage device and package identity while sourcing and scanning
  • Maintain qualified and validated software components to manage regulated, compliant medical devices.

A major challenge to the global pharmaceutical/medical device supply chain is the prevalence of counterfeit drugs and devices. PharmaLedger, an EU-funded public-private partnership is developing an electronic product information and product authentication capability which can be adopted as a common solution for the industry and patients.

  • PharmaLedger project overview
  • Scope of the electronic product information and anti-counterfeiting use cases
  • Patient engagement and empowerment to verify product authenticity
With growing concerns around patient privacy, can blockchain technology be an efficient solution to managing electronic medical records?
  • Theorize uses for blockchain in securing patient data while enhancing data collection
  • Achieve interoperability by empowering and incentivizing patients to contribute to their health data
  • Examine global economic implications
Blockchain technology has penetrated nearly every global industry and its capabilities are continuing to evolve. Join our panelists as they discuss all the ways they see the life sciences ecosystem changing over the next decade.
  • Consider the implications of treating data like property
  • Address the regulatory and governance requirements
  • Discuss the global economic impact
Register Now

This window is secured by 256 bit encryption on a PCI compliant network. Click here to view this window in its own page.

Subscribe to Conference Updates
Join our e-newsletter list to follow closely all news.
Event Partners
Contact Us